ImmunoDiagnostics Overview
- Year Founded
-
2004

- Status
-
Acquired/Merged
- Employees
-
1,500

- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
1
ImmunoDiagnostics General Information
Description
Manufacturer of blood testing systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases. The company also provides Varelisa for the detection of autoantibodies; EliA, an automated system for the measurement of autoantibodies; ImmunoCAP for measuring IgE antibodies; assays to support the diagnosis of celiac diseases; and ImmunoCAP Rapid Reader, which is used to aid in the diagnosis of allergy in a physician's office. It also develops and supports diagnostic tests for autoimmune diseases.
Contact Information
Website
www.phadia.comCorporate Office
- Munzinger Strasse 7
- 751 37 Uppsala
- Sweden
Corporate Office
- Munzinger Strasse 7
- 751 37 Uppsala
- Sweden
ImmunoDiagnostics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
ImmunoDiagnostics Patents
ImmunoDiagnostics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4278189-A1 | Novel allergen isoform variants | Pending | 13-Jan-2021 | ||
JP-2024503860-A | Novel allergen isoform variants | Pending | 13-Jan-2021 | ||
US-20220241406-A1 | Novel allergen | Pending | 05-Jul-2019 | ||
JP-2022538691-A | New allergen | Active | 05-Jul-2019 | ||
EP-3994155-A1 | Novel allergen | Pending | 05-Jul-2019 | A61K39/35 |
ImmunoDiagnostics Signals
ImmunoDiagnostics Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
ImmunoDiagnostics Investments (1)
ImmunoDiagnostics’s most recent deal was a Buyout/LBO with Pronostics. The deal was made on 01-Jan-2009.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Pronostics | 01-Jan-2009 | Buyout/LBO | Diagnostic Equipment |
ImmunoDiagnostics FAQs
-
When was ImmunoDiagnostics founded?
ImmunoDiagnostics was founded in 2004.
-
Where is ImmunoDiagnostics headquartered?
ImmunoDiagnostics is headquartered in Uppsala, Sweden.
-
What is the size of ImmunoDiagnostics?
ImmunoDiagnostics has 1,500 total employees.
-
What industry is ImmunoDiagnostics in?
ImmunoDiagnostics’s primary industry is Diagnostic Equipment.
-
Is ImmunoDiagnostics a private or public company?
ImmunoDiagnostics is a Private company.
-
What is the current valuation of ImmunoDiagnostics?
The current valuation of ImmunoDiagnostics is
. -
What is ImmunoDiagnostics’s current revenue?
The current revenue for ImmunoDiagnostics is
. -
How much funding has ImmunoDiagnostics raised over time?
ImmunoDiagnostics has raised $566M.
-
Who are ImmunoDiagnostics’s investors?
Ardian, Cinven, Pfizer (Pharmaceuticals), Silverfleet Capital, and Triton Partners have invested in ImmunoDiagnostics.
-
When was ImmunoDiagnostics acquired?
ImmunoDiagnostics was acquired on 23-Aug-2011.
-
Who acquired ImmunoDiagnostics?
ImmunoDiagnostics was acquired by Thermo Fisher Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »